DA
MRNA icon

Duality Advisers’s Moderna MRNA Stock Holding History

Duality Advisers’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-40,077
Closed -$4.14M – 679
2023
Q3 		$4.14M Buy
40,077
+3,489
+10% +$389K 0.5% 35
2023
Q2 		$4.45M Buy
36,588
+9,652
+36% +$1.29M 0.56% 23
2023
Q1 		$4.14M Buy
+26,936
New +$4.44M 0.47% 44
2022
Q1 		– Sell
-5,248
Closed -$1.33M – 758
2021
Q4 		$1.33M Sell
5,248
-4,668
-47% -$1.36M 0.14% 243
2021
Q3 		$3.82M Buy
9,916
+1,140
+13% +$420K 0.29% 131
2021
Q2 		$2.06M Sell
8,776
-25,778
-75% -$4.61M 0.18% 198
2021
Q1 		$4.53M Sell
34,554
-50,612
-59% -$7.33M 0.39% 64
2020
Q4 		$8.9M Buy
+85,166
New +$8.62M 0.66% 24

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Duality Advisers's MRNA Position: Q4 2023 in Review

Duality Advisers sold out of Moderna (MRNA) in Q4 2023, closing a stake of 40,077 shares — an estimated $4.14M sold.

Duality Advisers first reported a position in MRNA in Q4 2020 and held it in 8 quarters. The position peaked at $8.9M in Q4 2020. 885 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Duality Advisers reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Duality Advisers sold 40,077 Moderna shares in Q4 2023, an estimated $4.14M.
  • Duality Advisers first reported a position in Moderna in Q4 2020 and held it in 8 quarters.
  • Duality Advisers's Moderna position peaked at $8.9M in Q4 2020.
  • 885 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Duality Advisers's 13F filing for Q4 2023, filed 1 Feb 2024.